DEFACTO selects VIVEbiotech to include it in its project
The marketing and communication consultancy DEFACTO has selected VIVEbiotech as a chameleon company that has known how to adapt to the COVID-19 crisis.
In this project called Los camaleones que confundieron a la pandemia (The chameleons that confused the pandemic), DEFACTO tries to make visible business projects that have demonstrated good management -both long-term and more recently-, resilience and flexibility to adapt to the coronavirus crisis.
In this interview with Gurutz Linazasoro, CEO, and José Manuel Franco, COO, DEFACTO introduces who we are and what we do at VIVEbiotech.
Many thanks to DEFACTO for this interesting initiative and for dedicating a few words to VIVEbiotech.
To read the full interview, you can click here.